1. Home
  2. RNG vs CNTA Comparison

RNG vs CNTA Comparison

Compare RNG & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RingCentral Inc.

RNG

RingCentral Inc.

HOLD

Current Price

$33.15

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$39.64

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNG
CNTA
Founded
1999
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.5B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
RNG
CNTA
Price
$33.15
$39.64
Analyst Decision
Hold
Buy
Analyst Count
14
9
Target Price
$33.58
$42.00
AVG Volume (30 Days)
1.4M
4.2M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
0.81%
N/A
EPS Growth
176.19
29.13
EPS
0.48
N/A
Revenue
$2,515,142,000.00
$15,000,000.00
Revenue This Year
$5.56
N/A
Revenue Next Year
$4.56
N/A
P/E Ratio
$76.93
N/A
Revenue Growth
4.78
N/A
52 Week Low
$21.91
$10.95
52 Week High
$42.42
$40.26

Technical Indicators

Market Signals
Indicator
RNG
CNTA
Relative Strength Index (RSI) 38.65 76.90
Support Level $25.58 $24.80
Resistance Level $39.74 $40.26
Average True Range (ATR) 2.02 1.07
MACD -0.49 0.80
Stochastic Oscillator 1.48 96.49

Price Performance

Historical Comparison
RNG
CNTA

About RNG RingCentral Inc.

RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: